AJANTPHARMPharmaceuticals
Ajanta Pharma Ltd — PE Ratio & Valuation Analysis
₹2805.10
-2.50%
Current P/E32.94xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E37.6x12.5% below avg
⚠️
3.7% Premium to Industry
AJANTPHARM P/E 32.94x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹73.53 | ₹2769 | 37.7x |
| 2024 | ₹64.77 | ₹2932 | 45.3x |
| 2023 | ₹45.89 | ₹2084 | 45.4x |
| 2022 | ₹54.96 | ₹1212 | 22.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Ajanta Pharma Ltd Valuation
Ajanta Pharma Ltd (AJANTPHARM) currently trades at 32.94x earnings. The Pharmaceuticals sector average PE is 31.77x. AJANTPHARM commands a premium, reflecting high growth expectations. Historically, AJANTPHARM has traded at an average PE of 37.6x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
24.91%
Dividend Yield
1.09%
More on Ajanta Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.